TP53 and nasopharyngeal carcinoma: In nasopharyngeal carcinoma (NPC), ref. [57] found that adding a p53 gene therapy adenovirus to radiotherapy did not significantly improve 5-year OS (66.7% vs. 59.2%, p = 0.34).